The phospholipids of rabbit alveolar macrophages were pulse-labelled with [14C]-arachidonic acid, and the subsequent release of labelled prostaglandins was measured. Resting macrophages released measurable amounts of arachidonic acid, the prostaglandins E2, D2 and F2<, and 6-oxoprostaglandin F1Q,. Phagocytosis of zymosan increased the release of arachidonic acid and prostaglandins to 2.5 times the control value. In contrast, phagocytosis of inert latex particles had no effect on prostaglandin release. Indomethacin inhibited the release of prostaglandin, and, at high doses (20,ug/ml), increased arachidonic acid release. Analysis ofthe cellular lipids showed that after zymosan stimulation the proportion of label was decreased in phosphatidylcholine, but not in other phospholipids or neutral lipids. Cytochalasin B, at a dose of 2,ug/ml, inhibited the phagocytosis induced by zymosan but increased prostaglandin synthesis to 3.4 times the control. These data suggest that the stimulation of prostaglandin synthesis by zymosan is not dependent on phagocytosis. Exposure to zymosan also resulted in the release of the lysosomal enzyme, acid phosphatase. Furthermore, cytochalasin B augmented the zymosan-stimulated release of acid phosphatase at the same dose that stimulated prostaglandin synthesis. However, indomethacin, at a dose that completely inhibited prostaglandin synthesis, failed to block the lysosomal enzyme release. Thus despite some parallels between the release of prostaglandins and lysosomal enzymes, endogenous prostaglandins do not appear to mediate the release of lysosomal enzymes. The prostaglandins released from the macrophages may function as humoral substances affecting other cells.
The role of lysosomal enzymes as mediators of the inflammatory reactions is well documented (Weissman, 1965; Cochrane, 1968; Becker & Henson, 1973) . Endocytic stimuli result in increased lysosomal enzyme activity in mouse peritoneal macrophages (Weissman, 1965; de Duve & Wattiaux, 1966; Weissman et al., 1971 ) and polymorphonuclear leucocytes (Weissman, 1965; de Duve & Wattiaux, 1966) . However, the mechanisms for lysosomal enzyme induction are poorly understood. Since prostaglandins are also mediators of inflammation (Willis, 1969; Williams & Morley, 1973) and are produced in response to phagocytic stimuli, it is important to examine the relationship between their production and lysosomal enzyme release.
The principal objectives of the present investigation are to identify the various prostaglandins secreted by rabbit alveolar macrophages and to examine their relationship to phagocytosis. Cytochalasin B was used in an effort to dissect the process of phagocytic stimulation into stages, since this drug inhibits the interiorization of particles, but does not interfere with the attachment of the particle to the macrophage membrane (Allison et al., 1971; Axline & Reaven, 1974) . We have also examined that relationship between prostaglandin production and lysosomal enzyme release.
Prostaglandins are not stored preformed in cells. Intracellular concentrations of free fatty acids, including the precursors of prostaglandins, are very low (Piper & Vane, 1971) . Consequently, the synthesis of prostaglandins requires the activation of cell lipases to release the precursor, arachidonic acid, from bound tissue lipid, predominantly phospholipid (Flower &Blackwell, 1976; Bills etal., 1976) . We have previously developed methods to incorporate ("4C] arachidonic acid into the tissue lipid pool in both isolated organs (Isakson et al., 1976) and tissue culture (Jakschik et al., 1978) and to measure the free arachidonic acid release by using fatty acid-free bovine serum albumin to bind the released free fatty acid and prevent its use for reacylation (Isakson et al., 1977) . By labelling the precursor pool of macrophages and by measuring the subsequent release of radioactive arachidonic acid and prostaglandins, we obtain measures of both lipase activity and cyclo-oxygenase activity in these cells.
Materials and Methods

Chemicals
[14C]Arachidonic acid (sp. radioactivity 55 mCi/ mmol; Amersham/Searle, Arlington Heights, IL, U.S.A.) was prepared as the sodium salt in 0.9% NaCI by adjusting the pH to 9 with 0.1 M-NaOH. 
Preparation and incubation ofalveolar macrophages
Adult male New Zealand rabbits weighing 2-3 kg were anaesthetized with pentobarbital sodium (30mg/kg), and exsanguinated.
The thoracic cavity was opened and the lung was lavaged six times in situ through a tracheotomy with 50 ml ofsterile 0.15 M-NaCl containing 2.6 mM-EDTA.
Use of EDTA to chelate the bivalent cations Ca2+ and Mg2+ increases the cell yield (Brain & Frank, 1973) , and prevents the cells from adhering to the tube. The wash fluid was pooled and centrifuged at 800g for 10min. Small samples were taken for viability testing by Trypan Blue dye exclusion, and smears were prepared and fixed in ethanol for histological examination with haematoxylin and eosin stains. The collected cells were approx. 90% macrophages by morphological examination, and over 95 % were viable. The cells were counted in a haemocytometer, diluted, and 1 ml portions containing 6 x 106 cells were plated in 35mm Petri dishes in Dulbecco's modified Eagle's medium containing 15 % (v/v) foetal calf serum and 100i.u. of penicillin/ml and 100,ug of streptomycin/ml. The serum concentration (15 %) is known to provide optimal proliferation of mouse and hamster macrophages (Lin et al., 1975 with or without added drugs or particles. As phagocytic stimuli, zymosan (1mg/ml) or 1.1 ,um latex particles (0.1 mg/ml) were added to some cul-tures. Indomethacin (2,ug/ml or 20ug/ml) was used in some cultures to inhibit prostaglandin synthesis. Cytochalasin B was used initially in an attempt to separate effects due to the attachment phase of phagocytosis (not inhibited by cytochalasin B) from those due to particle uptake (inhibited by cytochalasin B) (Allison et al., 1971) . Two different concentrations of cytochalasin B, 0.5,g/ml and 2,pg/ml, were used in most experiments. A stock solution of cytochalasin B (I mg/ml) in dimethyl sulphoxide was diluted with Dulbecco's modified Eagle's medium to give the desired concentration. The highest concentration of dimethyl sulphoxide in the cultures was 0.2%o (v/v) which, by itself, did not affect prostaglandin secretion. In early experiments, to compare our results with published data (Humes et al., 1977) , we also examined prostaglandin production by mouse peritoneal macrophages, using cells collected 4 days after thioglycollate injection into the peritoneal cavity.
Enzyme determinations
Acid phosphatase activity was determined in both medium and cells by modification of the procedure of Leaback (1974) . To determine the intracellular enzyme content the cells were scraped off the plates into 0.3 ml of 0.1 % (v/v) Triton X-100 in water with a rubber 'policeman'. Portions of the cell lysates were diluted 10-fold with 0.2M-sodium acetate buffer (pH 5) for assay. Then 30,ul of the medium or diluted cell lysate was added to 70,l of 4-methylumbelliferyl phosphate (0.03mg/ml) in acetate buffer and incubated at 37°C for 15 min. The enzyme reaction was terminated by adding 1.9 ml of 0.02 M-sodium phosphate buffer (pH 10.7). The fluorescence was measured in a Farrand fluorimeter with a Corning 5860 primary filter and Corning 3387 and 5543 secondary filters. Vol. 184
Lactate dehydrogenase was assayed as described by Lowry & Passonneau (1972) : 20ul of undiluted supernatant or cell lysate was incubated in 2ml of substrate consisting of I mM-sodium pyruvate and 2uM-NADH in I mM-sodium phosphate buffer, pH7.0. The native fluorescence of the NADH was measured at 15 s intervals for 2 min with the Farrand fluorimeter equipped with a Corning 5860 primary filter and Corning 4303 and 3387 secondary filters.
Results
Incorporation of ['4C]arachidonic acid into cell lipids and release of [14C]prostaglandins after stimulation
Approx. 40 % of the radioactivity was incorporated into cell lipids of rabbit alveolar macrophages in 1 h under our incubation conditions; 65-70% of the incorporated radioactivity was in phospholipids, most in phosphatidylcholine (41.1±1.2% of total radioactivity in cells) and phosphatidylethanolamine (16.7±1.7%) (Fig. 1) . Only 11.1+2.2% of the intracellular label was in neutral lipid, and very little free arachidonic acid (1.9±0.4% of total intracellular radioactivity) was detected in the cell lipid extract. A comparison of the cell lipids of rabbit alveolar macrophages and mouse peritoneal macrophages showed similar patterns of incorporation, except for the presence of an unidentified peak (X; 15.4±1.3 % of intracellular radioactivity) migrating between fatty acid and neutral lipid in alveolar macrophages (Fig. 1) Analysis of the medium after zymosan stimulation with mouse peritoneal macrophages after thioglycollate injection confirmed previous observations that prostaglandin E2 was the single predominant prostaglandin produced by stimulated mouse peritoneal macrophages (Humes et al., 1977) . In contrast, rabbit alveolar macrophages released a mixture of prostaglandins E2, D2 and F2< and 6- oxoprostaglandin F1l (the stable metabolite of prostaglandins 12) after zymosan stimulation. Typical radiochemical scans of the medium after zymosan stimulation from mouse peritoneal macrophages and rabbit alveolar macrophages are shown in Fig. 1 or release of lactate dehydrogenase (Table 2) . It did result in a 2.5 times increase in prostaglandin synthesis (Fig. 2) . This increase could be inhibited by indomethacin (21ug/ml). Indomethacin did not exert any effect on phagocytosis (Table 2) . 1979 The media were extracted at the end ofthe experimental period (90 min), applied on the thin-layer plates and developed in solvent system 'A-9'. Zones corresponding to various prostaglandin standards were scraped off and counted for radioactivity. The total prostaglandin release (sum of6-oxo Fl,+ F2,+ E2 + D2) was calculated and expressed as the percentage of the control value (unstimulated cells). The following abbreviations are used: Z, zymosan (1 mg/ml); CB(o.3), cytochalasin B (0.5pg/ml); CB(2), cytochalasin B (2,pg/ml); I, indomethacin (20,pg/ml); L, latex particles (0.1 mg/ml). The numbers in circles are the numbers of experiments. Results are means ± S.E.M. Vol. 184
Effect of cytochalasin B on phagocytosis and prostaglandin release Addition of a low dose of cytochalasin B (0.5,ug/ ml) to zymosan-stimulated alveolar macrophages increased the total prostaglandin release to 3.4 times the value of unstimulated cells (Fig. 2) , a value significantly above that for zymosan alone (P<0.0l; Student's t test). Microscopic examination of the cells showed that cytochalasin B at this dose does not affect phagocytosis (Table 2 ). The prostaglandinstimulating effect was mediated via activation of the cell lipases (probably phospholipase), as indicated by a parallel increase in arachidonic acid release into the medium (Fig. 3) . Cytochalasin B at doses of 2,ug/ml and above inhibited phagocytosis (Table 2) . At 2,ug/ ml, cytochalasin B enhanced further the release of prostaglandins and arachidonic acid (Figs. 2 and 3) . However, increasing the dose of cytochalasin B to 5,ug/ml and 20,ug/ml failed to increase prostaglandin production further, despite an additional increment in deacylation (results not shown). Cytochalasin B without zymosan, or in combination with latex, had no effect on prostaglandin production or arachidonic acid release (Figs. 2 and 3) . Indomethacin (20,ug/ml) also had a facilitating effect on zymosan-induced arachidonic acid release (Fig. 3) . This effect was barely noticeable with 2,ug of indomethacin/ml. In the absence of zymosan or cytochalasin B, indomethacin had no effect on fatty acid release.
Effects of zymosan and cytochalasin B on lysosomal enzyme release Phagocytosis of zymosan by alveolar macrophages resulted in a 50 % increase in acid phosphatase release (Table 2 ). This increase was further augmented to 185% of the control value by the addition of cyto- chalasin B (0.5,ug/ml or 2,ug/ml). Neither cytochalasin B alone nor latex particles increased lysosomal enzyme release (results not shown). Indomethacin at a dose that completely inhibited prostaglandin synthesis (2pg/ml) did not significantly alter the acid phosphatase release.
Phospholipid source of released arachidonic acid Analysis ofthe cell lipids showed that the percentage of labelled arachidonic acid in phosphatidylcholine was decreased by 4 ± 0.7 % with zymosan stimulation (Fig. 4) . This loss increased to 7±0.7% with the addition of cytochalasin B in the presence of zymosan (Fig. 4) . The loss of radioactivity from phospholipid was roughly equivalent to the amount of radioactive prostaglandins and arachidonic acid released into the media. No decrease in labelled phosphatidylethanolamine, acidic phospholipid, neutral lipid, or X peak was detected after stimulation with either Vol. 184 zymosan or zymosan with cytochalasin B (Fig. 4) . Thus the main source of the arachidonic acid substrate for prostaglandin synthesis in stimulated macrophages appeared to be deacylation of phosphatidylcholine. Indomethacin, at the dose of 20,ug/ml, caused further loss of radioactivity from phosphatidylcholine (Fig. 4) . This effect was barely noticeable at the dose of 2,ug/ml.
Discussion
It has been shown that polymorphonuclear leucocytes and mouse peritoneal macrophages produce prostaglandins during phagocytosis (Higgs & Youlten, 1972; Bray et al., 1974; Higgs et al., 1975; Tolone et al., 1977; Glatt et al., 1977; Humes et al., 1977; Northover, 1977; Brune et al., 1978 ). The present study shows that rabbit alveolar macrophages also (Fig. 4) . These observations differ from those on platelets (Bills et al., 1977) , in which both phosphatidylcholine and phosphatidylinositol were reported to be sources of deacylation for prostaglandin and thromboxane synthesis. We believe that this change in the proportion of label in the various lipid classes was related to prostaglandin synthesis and did not result simply from interiorization of the endocytic membrane during particle ingestion, with subsequent redistribution of the membrane lipids, since interiorization of latex particles did not cause either a change in the distribution of label between lipid classes or in prostaglandin synthesis.
We also observed that indomethacin, especially at a high dose (20gg/ml), augmented arachidonic acid release from stimulated alveolar macrophages. (Brune et al., 1978) . Goldstein et al. (1978) have also observed that cytochalasin B inhibited zymosan uptake by polymorphonuclear leucocytes, without diminishing the stimulation of prostaglandin and thromboxane synthesis. In the polymorphonuclear leucocyte, however, cytochalasin B did not increase prostaglandin secretion above that produced by zymosan alone. The observations with both cell types suggest that it is the interaction of the zymosan with the membrane of the phagocyte or the resultant metabolic changes (Schnyder & Baggiolini, 1978) , rather than the uptake of the zymosan, that is the stimulus to secretion.
Cytochalasin B stimulates macrophages to increase secretion not only of prostaglandins, but also of elastase, collagenase (Gordon & Werb, 1976 ) and lysosomal enzymes (Davies et al., 1973; Ackerman & Beebe, 1975) . In constrast with our finding that cytochalasin B at low doses required zymosan to increase release of lysosomal enzymes, with the larger doses and longer incubation used in the above studies, cytochalasin B stimulated lysosomal enzyme release even in the absence of phagocytosis.
Our initial observations raised the possibility of a direct relationship between lysosomal enzyme release and secretion of prostaglandins. Both processes were evoked by the inflammatory stimulus, zymosan, but not by inert latex particles. Both prostaglandin release and lysosomal enzyme release were stimulated by the addition of cytochalasin B to zymosantreated cells, whereas cytochalasin B alone had no effect. We can exclude a regulatory role of prostaglandins on lysosomal enzyme release, since inhibition of prostaglandin synthesis by indomethacin did not alter lysosomal enzyme release and since Ackerman & Beebe (1975) had previously found that exogenous prostaglandins (El, E2, Fl, and F2<,) had no effect on the release of f-glucuronidase from guinea-pig alveolar macrophages. During the preparation of this paper, Bonney et al. (1978) (Franson & Waite, 1973) . Hence it is possible that during the redistribution of lysosomal enzymes that accompanies zymosan or zymosan and cytochalasin B stimulation, lysosomal phospholipase A2 has access to a lipid pool from which it is otherwise separated. Further studies have provided evidence for a variety of secretory functions for macrophages (Unanue, 1976 (Unanue, , 1977 . Macrophages have been reported to secrete mitogenic factors that influence granulopoiesis (Golde et al., 1972) , B-and Tlymphocyte function , fibroblast proliferation (Leibovich & Ross, 1975 , 1976 and angiogenesis (Polverini et al., 1977) . Several investigations have pointed to prostaglandins being among the mediators that are responsible for the interactions between macrophages and other cells. For instance, macrophage prostaglandins have been suggested to depress myelopoiesis induced by colonystimulating factor , to depress lymphokine production , to depress the plaque-forming response to autologous erythrocyte antigen (Zimecki & Webb, 1977) , to prevent enhancement of B-lymphocyte colony formation by macrophages (Kurland et al., 1977) and to depress the mitogenic response of T-lymphocytes in Hodgkin's disease (Goodwin et al., 1977) . The present investigation has shown that alveolar macrophages can be stimulated to synthesize and release a variety of prostaglandins. These products may help regulate the activities of lymphocytes and other target cells.
